$SOHU

Sohu.com Q2 Earnings Call Highlights

Sohu.com (NASDAQ:SOHU) reported Q2 call highlights, citing sequential growth in marketing services revenue but a weak advertising environment as advertisers stay cautious and shift toward social and influencer-driven marketing. Management forecast Q3 marketing services revenue of $40M-$50M, online game revenue $105M-$115M, and GAAP/non-GAAP net loss of $30M-$23M. Sohu repurchased 9.4M ADS for about $124M, with up to $150M authorized.

Original reporting
Published Aug 12, 2026, 1:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sohu.com Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$SOHUNeutralMed
01

Why it matters

Traders can update near-term expectations using the disclosed Q3 revenue and net loss ranges, and assess whether the open-ended buyback changes the balance between dilution risk and support.

02

Market read

Q3 guidance and the repurchase authorization update are the actionable items, with macro caution and category mix shaping the outlook.

03

What to watch

The guidance is subject to substantial uncertainty, and the games segment may be supported by older-title expansion pack performance even as management expects natural decline.

Relevance 7/10Novelty 7/10Timing: pre-market today (earnings call highlights and Q3 guidance released)

Background

The piece summarizes Sohu’s Q2 discussion, including ad-market weakness, game content updates, and management’s Q3 outlook and repurchase status.

Company-level read

Ticker impact

$SOHUNeutralMedium confidence
Context

Sohu guided Q3 marketing services revenue to $40M-$50M and online game revenue to $105M-$115M, plus GAAP/non-GAAP net loss $30M-$23M.

Expected impact

Near-term volatility likely around the guidance ranges and the updated open-ended $150M buyback authorization.

Evidence & confidence

The article provides specific Q3 revenue and net loss ranges and a concrete repurchase update, which can drive earnings-model revisions and sentiment.

Market effects

Highlights ongoing caution in China online advertising and a shift toward social and KOL-driven marketing formats.

Reinforces risk sentiment around China internet/media ad demand and ad budgets.

Limited direct global spillover, but it can affect sentiment for China-focused ad and gaming-adjacent platforms.

Counterpoint

Outperformance versus forecast suggests management can defend revenue even in a weak ad macro, potentially reducing downside risk versus the headline weakness.

Key entities

  • Sohu.com Inc

    NASDAQ-listed China online portal and advertising and gaming business; provided Q3 guidance and updated share repurchase authorization.

  • Charles Zhang

    Spoke on the weak advertising environment, marketing mix, and World Cup impact expectations.

  • Dewen Chen

    Changyou CEO; discussed older-game performance and expectations for Q3 content reception.

Related articles

$SOHUMed

3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs

Sohu.com (SOHU), Onity Group (ONIT), and TriMas (TRS) trade at low P/E ratios (1.6x, 2.3x, 1.6x respectively) despite showing signs of business strength. SOHU reported 7% YOY revenue growth and improved profitability. ONIT saw 24% YOY revenue growth and 64% origination growth but faced servicing headwinds. TRS showed 1.6% YOY sales growth and 29% operating profit increase, with raised earnings guidance.

$SOHUMedAI 8/10

Sohu (SOHU) Q2 2026 Earnings Call Transcript

Sohu.com Limited (SOHU) reported Q2 2026 revenue of $136 million, up 7% YoY but down 4% QoQ. Online games were $116 million, up 10% YoY, while marketing services were $15 million. GAAP net income was $0.2 million after a ~$30 million tax reversal; non-GAAP net income was $0.5 million. The company also said it repurchased 9.4M ADS for ~$124M and authorized more up to $150M. Q3 guidance: marketing services $40M-$50M; online games $105M-$150M.

$SOHUMed

Sohu.com Ltd (SOHU): Financial results for Q2 2026

Sohu.com Ltd (SOHU) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 SOHU.COM REPORTS SECOND QUARTER 2026 UNAUDITED FINANCIAL RESULTS BEIJING, Aug 10, 2026 –Sohu.com Limited (NASDAQ: SOHU) (“Sohu” or the “Company”), a leading Chinese online media platform and game business group, today reported unaudited financial results for the seco

$SOHUMedAI 8/10

SOHU.COM REPORTS SECOND QUARTER 2026 UNAUDITED FINANCIAL RESULTS

Sohu.com Limited (NASDAQ: SOHU) reported Q2 2026 unaudited results. Total revenue was $136m, up 7% YoY and down 4% QoQ. GAAP net income was $0.2m after a ~$13m tax expense reversal; non-GAAP net income was $0.5m. The board amended its ADS repurchase program to open-ended; $124m spent on 9.4m ADS as of Aug 6. Q3 guidance: marketing $14m-$15m, online games $105m-$115m, GAAP/non-GAAP net loss $13m-$23m.

$AAPLMed

Asia’s Tech Stocks Take the Hit as Apple and Microsoft Push Chip Costs to Consumers

Apple raised MacBook and iPad prices by up to $300 on June 25, citing higher memory and storage chip costs tied to AI data-center demand; its shares closed down more than 6%. Microsoft followed with Xbox price increases of $100–$150 effective Aug. 1; its stock fell 3.5%. The announcements helped drive an Asian selloff, with South Korea’s KOSPI dropping to about 8,600 early, and chip stocks like SK Hynix and Samsung down over 4%.

$IPHAMed

Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript

Innate Pharma (IPHA) reported Q2 2026 earnings, highlighting a cash position of -€21.4M, a $75M upfront payment from Sobi, and -€28M in net equity proceeds. H1 2026 net loss was -€19.6M, with revenue of -€5.7M. The company extended its cash runway to Q1 2028 and anticipates key milestones, including a Phase 3 readout for monalizumab and initial data for IPH4502. Management expects to file for accelerated approval of lacutamab in Sezary Syndrome in H2 2027.